NICE public health guidance makes recommendations for England on what is known from research and practice about the effectiveness and cost effectiveness of interventions and broader programmes, including the systems in which they are delivered, and the methods used to deliver them.
NICE public health guidance is relevant to health professionals working in clinical and community settings, and commissioners, managers and team leaders with responsibility for health improvement in the NHS, local authorities, schools, and public, private and voluntary sectors. It is also relevant to people interested in improving their own health or the health of their children or other people they care for, and to the wider community.
The Centre for Clinical Practice develops clinical guidelines which form recommendations on the appropriate treatment and care of people with specific diseases and conditions within the NHS. They are based on the best available evidence. Guidelines help health professionals in their work, but they do not replace their knowledge and skills.
|Consultation on draft scope by stakeholders:||29 November 2012 - 10 January 2013|
|Consultation on draft guidance:||22 July - 9 September 2014|
|Expected date of issue:||October 2015|
|Associate Director:||Catherine Swann|
|Lead Analyst:||Rachel Kettle|
|Health Economist:||Alastair Fischer|
|Public involvement Lead:||Jessica Fielding|
|Guidelines Development Group:||The Guideline Development Group (GDG) oversees the development process|
|Project Email Address:||PHupdatetuberculosis@nice.org.uk|
To be confirmed
National organisations wishing to register as a stakeholder can do so via the link below.
The draft scope is out for consultation with stakeholders. The scope defines what aspects of care the guideline will cover and to whom it will apply. If you wish to comment, you need to do so via one of the registered stakeholder organisations listed, by the deadline shown.
This is an update of CG117 Tuberculosis - clinical diagnosis and management of tuberculosis, and measures for its prevention and control, incorporating PH37 Tuberculosis - Hard to reach Groups. To register as a stakeholder please access the clinical guidelines page.